S&P 500   3,954.02 (-0.09%)
DOW   33,757.03 (-0.28%)
QQQ   281.11 (+0.19%)
AAPL   141.58 (+0.29%)
MSFT   242.70 (+0.99%)
META   109.66 (+0.18%)
GOOGL   94.99 (-0.21%)
AMZN   91.78 (-0.69%)
TSLA   184.56 (+2.06%)
NVDA   158.43 (+1.30%)
NIO   12.10 (+15.24%)
BABA   83.79 (+4.92%)
AMD   74.04 (+0.89%)
T   18.85 (-0.84%)
MU   53.71 (-2.56%)
F   13.57 (-1.31%)
GE   84.94 (-0.84%)
DIS   94.46 (-0.24%)
AMC   7.24 (-2.56%)
PYPL   77.00 (-0.82%)
PFE   49.25 (-0.48%)
NFLX   281.00 (+0.01%)
S&P 500   3,954.02 (-0.09%)
DOW   33,757.03 (-0.28%)
QQQ   281.11 (+0.19%)
AAPL   141.58 (+0.29%)
MSFT   242.70 (+0.99%)
META   109.66 (+0.18%)
GOOGL   94.99 (-0.21%)
AMZN   91.78 (-0.69%)
TSLA   184.56 (+2.06%)
NVDA   158.43 (+1.30%)
NIO   12.10 (+15.24%)
BABA   83.79 (+4.92%)
AMD   74.04 (+0.89%)
T   18.85 (-0.84%)
MU   53.71 (-2.56%)
F   13.57 (-1.31%)
GE   84.94 (-0.84%)
DIS   94.46 (-0.24%)
AMC   7.24 (-2.56%)
PYPL   77.00 (-0.82%)
PFE   49.25 (-0.48%)
NFLX   281.00 (+0.01%)
S&P 500   3,954.02 (-0.09%)
DOW   33,757.03 (-0.28%)
QQQ   281.11 (+0.19%)
AAPL   141.58 (+0.29%)
MSFT   242.70 (+0.99%)
META   109.66 (+0.18%)
GOOGL   94.99 (-0.21%)
AMZN   91.78 (-0.69%)
TSLA   184.56 (+2.06%)
NVDA   158.43 (+1.30%)
NIO   12.10 (+15.24%)
BABA   83.79 (+4.92%)
AMD   74.04 (+0.89%)
T   18.85 (-0.84%)
MU   53.71 (-2.56%)
F   13.57 (-1.31%)
GE   84.94 (-0.84%)
DIS   94.46 (-0.24%)
AMC   7.24 (-2.56%)
PYPL   77.00 (-0.82%)
PFE   49.25 (-0.48%)
NFLX   281.00 (+0.01%)
S&P 500   3,954.02 (-0.09%)
DOW   33,757.03 (-0.28%)
QQQ   281.11 (+0.19%)
AAPL   141.58 (+0.29%)
MSFT   242.70 (+0.99%)
META   109.66 (+0.18%)
GOOGL   94.99 (-0.21%)
AMZN   91.78 (-0.69%)
TSLA   184.56 (+2.06%)
NVDA   158.43 (+1.30%)
NIO   12.10 (+15.24%)
BABA   83.79 (+4.92%)
AMD   74.04 (+0.89%)
T   18.85 (-0.84%)
MU   53.71 (-2.56%)
F   13.57 (-1.31%)
GE   84.94 (-0.84%)
DIS   94.46 (-0.24%)
AMC   7.24 (-2.56%)
PYPL   77.00 (-0.82%)
PFE   49.25 (-0.48%)
NFLX   281.00 (+0.01%)
NASDAQ:CDNA

CareDx - CDNA Stock Forecast, Price & News

$12.20
+0.14 (+1.16%)
(As of 11/30/2022 09:39 AM ET)
Add
Compare
Today's Range
$12.08
▼
$12.25
50-Day Range
$12.06
▼
$20.05
52-Week Range
$11.92
▼
$47.82
Volume
610 shs
Average Volume
1.10 million shs
Market Capitalization
$653.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$46.20

CareDx MarketRank™ Forecast

Analyst Rating
Buy
3.25 Rating Score
Upside/​Downside
283.1% Upside
$46.20 Price Target
Short Interest
Healthy
8.55% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.44) to ($1.03) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

419th out of 1,043 stocks

Medical Laboratories Industry

12th out of 26 stocks

See Top Rated MarketRank™ Stocks Here
CDNA stock logo

About CareDx (NASDAQ:CDNA) Stock

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Receive CDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter.

CDNA Stock News Headlines

November 17, 2022 | finance.yahoo.com
Here's Why CareDx (CDNA) Could be Great Choice for a Bottom Fisher
November 11, 2022 | finance.yahoo.com
CareDx (CDNA) Loses 22.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
November 11, 2022 | finance.yahoo.com
CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community
November 6, 2022 | finance.yahoo.com
Analysts Have Been Trimming Their CareDx, Inc (NASDAQ:CDNA) Price Target After Its Latest Report
November 2, 2022 | finance.yahoo.com
CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week
November 1, 2022 | finance.yahoo.com
Do You Think CareDx (CDNA) Has Huge Growth Potential?
November 1, 2022 | finance.yahoo.com
Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients
October 27, 2022 | finance.yahoo.com
CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System
October 26, 2022 | finance.yahoo.com
CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients
October 26, 2022 | finance.yahoo.com
CareDx to Report Third Quarter 2022 Financial Results
October 25, 2022 | reuters.com
CDNA.A - CareDx Inc | Stock Price & Latest News | Reuters
October 25, 2022 | finance.yahoo.com
CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting
October 6, 2022 | finance.yahoo.com
JUNO DIAGNOSTICS ANNOUNCES APPOINTMENT OF TODD WHITSON AS EVP, GLOBAL BUSINESS DEVELOPMENT AND COMMERCIAL OPERATIONS - Yahoo Finance
September 29, 2022 | businesswire.com
CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care - Business Wire
September 29, 2022 | finance.yahoo.com
CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care
September 28, 2022 | fool.com
CareDx, Inc. (NASDAQ: CDNA)
September 28, 2022 | benzinga.com
CareDx, Inc. Investor News: Robbins LLP is Investigating CareDx, Inc. (CDNA) on Behalf of Shareholders
September 27, 2022 | businesswire.com
Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions - Business Wire
September 27, 2022 | finance.yahoo.com
Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions
September 26, 2022 | businesswire.com
CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List - Business Wire
September 26, 2022 | finance.yahoo.com
CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List
September 21, 2022 | finance.yahoo.com
CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference - Yahoo Finance
September 21, 2022 | uk.investing.com
Cathie Wood Cuts $32M From Healthcare Company In Which Amazon Is Reportedly Interested By Benzinga - Investing.com UK
September 19, 2022 | businesswire.com
CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference - Business Wire
September 19, 2022 | finance.yahoo.com
CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference
See More Headlines
Receive CDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter.

CDNA Company Calendar

Last Earnings
10/28/2021
Today
11/30/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CDNA
CUSIP
N/A
CIK
1217234
Web
www.caredxinc.com
Phone
(415) 287-2300
Fax
415-287-2450
Employees
633
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$46.20
High Stock Price Forecast
$87.00
Low Stock Price Forecast
$26.00
Forecasted Upside/Downside
+278.7%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
4 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-30,660,000.00
Net Margins
-23.36%
Pretax Margin
-23.58%
Return on Equity
-16.51%
Return on Assets
-13.54%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.52
Quick Ratio
5.27

Sales & Book Value

Annual Sales
$296.40 million
Price / Sales
2.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.16 per share
Price / Book
1.50

Miscellaneous

Outstanding Shares
53,540,000
Free Float
50,860,000
Market Cap
$653.19 million
Optionable
Optionable
Beta
1.03

Key Executives

  • Dr. Reginald SeetoDr. Reginald Seeto (Age 50)
    Pres, CEO & Director
    Comp: $1.51M
  • Dr. Peter Maag Ph.D. (Age 55)
    Exec. Director
    Comp: $791.45k
  • Ms. Sasha King M.B.A.Ms. Sasha King M.B.A. (Age 36)
    Exec. Officer
    Comp: $628.87k
  • Mr. Marcel Konrad (Age 46)
    Sr. VP of Fin. & Accounting
    Comp: $167.96k
  • Mr. Alexander L. Johnson (Age 48)
    Pres of Patient and Testing Services
    Comp: $716.54k
  • Mr. Abhishek Jain (Age 46)
    CFO, VP, Corp. Controller, Principal Financial Officer & Principal Accounting Officer
  • Ms. Marica Grskovic Ph.D.
    Chief Operating Officer
  • Mr. Abraham Ronai Esq. (Age 49)
    Gen. Counsel, Chief Admin. & Legal Officer and Sec.
  • Mr. Ian Cooney
    VP of Investor Relations
  • Dr. Mickey Y. Kim M.D.
    Sr. VP of Corp. Devel. & Head of Global Product

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













CDNA Stock - Frequently Asked Questions

Should I buy or sell CareDx stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CDNA shares.
View CDNA analyst ratings or view top-rated stocks.

What is CareDx's stock price forecast for 2023?

4 analysts have issued 1-year target prices for CareDx's stock. Their CDNA share price forecasts range from $26.00 to $87.00. On average, they predict the company's stock price to reach $46.20 in the next year. This suggests a possible upside of 283.1% from the stock's current price.
View analysts price targets for CDNA or view top-rated stocks among Wall Street analysts.

How have CDNA shares performed in 2022?

CareDx's stock was trading at $45.48 on January 1st, 2022. Since then, CDNA stock has decreased by 73.5% and is now trading at $12.06.
View the best growth stocks for 2022 here.

When is CareDx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our CDNA earnings forecast.

How were CareDx's earnings last quarter?

CareDx, Inc (NASDAQ:CDNA) issued its earnings results on Thursday, October, 28th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.14) by $0.21. The company had revenue of $75.60 million for the quarter, compared to analyst estimates of $74.11 million. CareDx had a negative net margin of 23.36% and a negative trailing twelve-month return on equity of 16.51%. The company's quarterly revenue was up 41.6% compared to the same quarter last year. During the same period last year, the company posted ($0.06) earnings per share.

What guidance has CareDx issued on next quarter's earnings?

CareDx issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $320.00 million-$325.00 million, compared to the consensus revenue estimate of $327.79 million.

What other stocks do shareholders of CareDx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Block (SQ), Roku (ROKU), Exact Sciences (EXAS), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Enphase Energy (ENPH), Johnson & Johnson (JNJ), Activision Blizzard (ATVI) and Alibaba Group (BABA).

What is CareDx's stock symbol?

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

Who are CareDx's major shareholders?

CareDx's stock is owned by many different institutional and retail investors. Top institutional investors include ARK Investment Management LLC (10.83%), Vanguard Group Inc. (9.46%), State Street Corp (7.93%), BlackRock Inc. (7.49%), Bellevue Group AG (4.86%) and Sumitomo Mitsui Trust Holdings Inc. (4.65%). Insiders that own company stock include Ankur Dhingra, George Bickerstaff, Grace Colon, Michael Brian Bell, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas and William A Hagstrom.
View institutional ownership trends.

How do I buy shares of CareDx?

Shares of CDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CareDx's stock price today?

One share of CDNA stock can currently be purchased for approximately $12.06.

How much money does CareDx make?

CareDx (NASDAQ:CDNA) has a market capitalization of $645.66 million and generates $296.40 million in revenue each year. The company earns $-30,660,000.00 in net income (profit) each year or ($1.41) on an earnings per share basis.

How many employees does CareDx have?

The company employs 633 workers across the globe.

How can I contact CareDx?

CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.caredxinc.com. The company can be reached via phone at (415) 287-2300, via email at caroline.corner@westwicke.com, or via fax at 415-287-2450.

This page (NASDAQ:CDNA) was last updated on 11/30/2022 by MarketBeat.com Staff